{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:02:51Z","timestamp":1740135771450,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Digit Imaging"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10278-023-00896-9","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T17:01:42Z","timestamp":1693933302000},"page":"2382-2391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pulmonary Surface Irregularity Score as a New Quantitative CT Marker for Idiopathic Pulmonary Fibrosis\u2014a Pilot Study"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0536-4239","authenticated-orcid":false,"given":"Asser M. Abou","family":"Elkassem","sequence":"first","affiliation":[]},{"given":"Rafah","family":"Mresh","sequence":"additional","affiliation":[]},{"given":"Ahmed","family":"Farag","sequence":"additional","affiliation":[]},{"given":"Steven","family":"Rothenberg","sequence":"additional","affiliation":[]},{"given":"Seth T.","family":"Lirette","sequence":"additional","affiliation":[]},{"given":"Andrew D.","family":"Smith","sequence":"additional","affiliation":[]},{"given":"Tejaswini","family":"Kulkarni","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"896_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet 2017; 389:1941-1952","journal-title":"Lancet"},{"key":"896_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","volume":"183","author":"B Ley","year":"2011","unstructured":"Ley B, Collard HR, King TE, Jr. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011; 183:431-440","journal-title":"Am J Respir Crit Care Med"},{"key":"896_CR3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, et al. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788-824","journal-title":"Am J Respir Crit Care Med"},{"key":"896_CR4","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.rmed.2015.02.002","volume":"109","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Perlman D, Tomic R. Natural history of idiopathic pulmonary fibrosis. Respir Med 2015; 109:661-670","journal-title":"Respir Med"},{"key":"896_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1148\/radiol.221381","volume":"305","author":"F Gleeson","year":"2022","unstructured":"Gleeson F, Fraser E. Hyperpolarized Xenon MRI, Further Evidence of Its Use in Progressive Pulmonary Fibrosis? Radiology 2022; 305:697-698","journal-title":"Radiology"},{"key":"896_CR6","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1056\/NEJMe1403448","volume":"370","author":"GM Hunninghake","year":"2014","unstructured":"Hunninghake GM. A new hope for idiopathic pulmonary fibrosis. N Engl J Med 2014; 370:2142-2143","journal-title":"N Engl J Med"},{"key":"896_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/MCP.0000000000000091","volume":"20","author":"SD Nathan","year":"2014","unstructured":"Nathan SD, Meyer KC. IPF clinical trial design and endpoints. Curr Opin Pulm Med 2014; 20:463-471","journal-title":"Curr Opin Pulm Med"},{"key":"896_CR8","doi-asserted-by":"crossref","unstructured":"Wu X, Kim GH, Salisbury ML, et al. Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis. Am J Respir Crit Care Med 2019; 199:12\u201321","DOI":"10.1164\/rccm.201803-0444PP"},{"key":"896_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1148\/radiol.2015142202","volume":"277","author":"DC Sullivan","year":"2015","unstructured":"Sullivan DC, Obuchowski NA, Kessler LG, et al. Metrology Standards for Quantitative Imaging Biomarkers. Radiology 2015; 277:813-825","journal-title":"Radiology"},{"key":"896_CR10","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1164\/rccm.201201-0006PP","volume":"185","author":"G Raghu","year":"2012","unstructured":"Raghu G, Collard HR, Anstrom KJ, et al. Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med 2012; 185:1044-1048","journal-title":"Am J Respir Crit Care Med"},{"key":"896_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1378\/chest.10-2572","volume":"140","author":"SD Nathan","year":"2011","unstructured":"Nathan SD, Shlobin OA, Weir N, et al. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest 2011; 140:221-229","journal-title":"Chest"},{"key":"896_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","volume":"156","author":"B Ley","year":"2012","unstructured":"Ley B, Ryerson CJ, Vittinghoff E, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 2012; 156:684-691","journal-title":"Ann Intern Med"},{"key":"896_CR13","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.rcl.2016.05.004","volume":"54","author":"JE Kusmirek","year":"2016","unstructured":"Kusmirek JE, Martin MD, Kanne JP. Imaging of Idiopathic Pulmonary Fibrosis. Radiol Clin North Am 2016; 54:997-1014","journal-title":"Radiol Clin North Am"},{"key":"896_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/RTI.0000000000000204","volume":"31","author":"MD Martin","year":"2016","unstructured":"Martin MD, Chung JH, Kanne JP. Idiopathic Pulmonary Fibrosis. J Thorac Imaging 2016; 31:127-139","journal-title":"J Thorac Imaging"},{"key":"896_CR15","doi-asserted-by":"crossref","unstructured":"Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 2018; 198:e44-e68","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"896_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2214\/AJR.19.21144","volume":"213","author":"AD Smith","year":"2019","unstructured":"Smith AD, Porter KK, Elkassem AA, Sanyal R, Lockhart ME. Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis. AJR Am J Roentgenol 2019; 213:77-89","journal-title":"AJR Am J Roentgenol"},{"key":"896_CR17","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1007\/s00261-018-1617-x","volume":"43","author":"A Smith","year":"2018","unstructured":"Smith A, Varney E, Zand K, et al. Precision analysis of a quantitative CT liver surface nodularity score. Abdom Radiol (NY) 2018; 43:3307-3316","journal-title":"Abdom Radiol (NY)"},{"key":"896_CR18","doi-asserted-by":"crossref","unstructured":"Elkassem AA, Allen BC, Lirette ST, et al. Multiinstitutional Evaluation of the Liver Surface Nodularity Score on CT for Staging Liver Fibrosis and Predicting Liver-Related Events in Patients with Hepatitis C. AJR Am J Roentgenol 2021;","DOI":"10.2214\/AJR.21.27062"},{"key":"896_CR19","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1177\/1060028019862497","volume":"53","author":"R Pleasants","year":"2019","unstructured":"Pleasants R, Tighe RM. Management of Idiopathic Pulmonary Fibrosis. Ann Pharmacother 2019; 53:1238-1248","journal-title":"Ann Pharmacother"},{"key":"896_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1148\/rg.2020190099","volume":"40","author":"A Chen","year":"2020","unstructured":"Chen A, Karwoski RA, Gierada DS, Bartholmai BJ, Koo CW. Quantitative CT Analysis of Diffuse Lung Disease. Radiographics 2020; 40:28-43","journal-title":"Radiographics"},{"key":"896_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1183\/09059180.00002512","volume":"21","author":"L Nalysnyk","year":"2012","unstructured":"Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev 2012; 21:355-361","journal-title":"Eur Respir Rev"},{"key":"896_CR22","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","volume":"378","author":"TE King Jr","year":"2011","unstructured":"King TE, Jr., Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011; 378:1949-1961","journal-title":"Lancet"}],"container-title":["Journal of Digital Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-023-00896-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10278-023-00896-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-023-00896-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T21:52:29Z","timestamp":1702936349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10278-023-00896-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["896"],"URL":"https:\/\/doi.org\/10.1007\/s10278-023-00896-9","relation":{},"ISSN":["0897-1889","1618-727X"],"issn-type":[{"type":"print","value":"0897-1889"},{"type":"electronic","value":"1618-727X"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"19 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was waived for this institutional review board\u2013approved Health Insurance Portability and Accountability Act (HIPAA)\u2013compliant retrospective single-center observational pilot study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}